Ask AI
ProCE Banner Series

The Art of Therapeutic Balance: Innovations in Pancreatic Cancer Across the Disease Continuum

Join us in person or online for this interactive symposium in conjunction with ASCO 2026, in which an expert panel of oncologists will discuss treatment selection, sequencing, and toxicity mitigation across the continuum of pancreatic cancer—from resectable to metastatic disease.

Not an official event of the 2026 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is designed for community oncologists, advanced practice providers, oncology nurses, physician associates, pharmacists, and other healthcare professionals involved in the multidisciplinary care of patients with pancreatic cancer across all disease stages, aiming to improve frontline and later-line treatment outcomes.

All Events

The Art of Therapeutic Balance: Innovations in Pancreatic Cancer Across the Disease Continuum

Upcoming Events

May

29

2026

6:30 PM - 8:30 PM Central Time (CT)

In-person

Hilton Chicago, 720 S Michigan Ave, Chicago, Illinois 60625

7:00 PM - 8:30 PM Central Time (CT)

Virtual

Topics

Pancreatic Cancer

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This educational activity aims to enhance learners’ knowledge, confidence, and competence in understanding the latest scientific advances, interpreting emerging clinical trial and conference data, and applying evidence-based immunotherapy, targeted therapy, cytotoxic regimens, and novel modalities to optimize treatment selection, sequencing, and toxicity management in pancreatic cancer.

Target Audience
This activity is designed for community oncologists, advanced practice providers, oncology nurses, physician associates, pharmacists, and other healthcare professionals involved in the multidisciplinary care of patients with pancreatic cancer across all disease stages, aiming to improve frontline and later-line treatment outcomes.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess emerging biomarker and molecular profiling data to guide personalized treatment decisions that incorporate novel therapeutic modalities

  • Select frontline and subsequent therapies for pancreatic cancer using current clinical evidence and guideline-based criteria, tailored to disease stage, patient performance status, and molecular biomarker profiles

  • Implement practical dose modification, toxicity monitoring, and supportive care strategies to manage gastrointestinal, hematologic, and neuropathic adverse events associated with pancreatic cancer therapies

Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC dba Decera Clinical Education and the Pancreatic Cancer Action Network (PanCAN). Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education  

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Continuing Pharmacy Education

Clinical Care Options, LLC dba Decera Clinical Education designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-9999-26-255-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Decera Clinical Education’s Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

IPCE Credit Designation 

A logo for a credit companyAI-generated content may be incorrect. 

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change. 

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education, in partnership with the Pancreatic Cancer Action Network (PanCAN)

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Revolution Medicines, Inc.

Revolution Medicines, Inc.

Partners

Pancreatic Cancer Action Network (PanCAN)

ProCE Banner

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191